发明名称 Hydroxamic acid compounds as opioid kappa receptor agonists
摘要 <p>A compound of the following formula: <CHEM> and its pharmaceutically acceptable salt thereof, wherein R<1> and R<2> are independently hydrogen, C1-4 alkyl, C3-7 cycloalkyl, C2-4 alkenyl, C1-4 alkoxy-C1-4 alkyl, C1-4 alkylthio-C1-4 alkyl, phenyl, phenyl-C1-4alkyl, halo-substituted C1-4 alkyl, C3-7 cycloalkyl-C1-3 alkyl or hydroxy-C1-4alkyl ; or R<1> and R<2> are taken together with the nitrogen to which they are attached and form optionally substituted, saturated or unsaturated 3-, 4-, 5-, 6- or 7- membered heterocyclic cantaining one to two heteroatoms, provided that the heterocyclic is not pyrrolidinyl; R<3> is hydrogen, C1-4 alkyl or a hydroxy protecting group; Ar is optionally substituted phenyl or phenyl-C1-3 alkyl; and X is optionally substituted phenyl, naphthyl, biphenyl, indanyl, benzofuranyl, benzothiophenyl, 1-tetralone-6-yl, C1-4 alkylenedioxy, pyridyl, furyl or thienyl. These compounds and pharmaceutical compositions containing them are useful as analgesic, antiinflammatory, diuretic, antitussive, anesthetic or neuroprotective agents, or an agent for treatment of stroke or functional bowel disease such as abdominal pain, for the treatment of a mammalian subject, especially a human subject.</p>
申请公布号 EP0789021(A1) 申请公布日期 1997.08.13
申请号 EP19970200003 申请日期 1997.01.07
申请人 PFIZER INC. 发明人 ITO, FUMITAKA
分类号 C07D295/12;A61K31/00;A61K31/165;A61K31/395;A61K31/40;A61K31/445;A61K31/4453;A61K31/55;A61P7/00;A61P7/10;A61P11/00;A61P11/14;A61P25/00;A61P25/04;A61P29/00;C07C259/06;C07D205/04;C07D207/20;C07D211/70;C07D295/125;(IPC1-7):C07D295/12;A61K31/16 主分类号 C07D295/12
代理机构 代理人
主权项
地址